author-photo

Iino Fumie

1

Papers

3

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.

2020 Kidney International
Show All
- Source
- Cite
- Save
Citations (3)